Hsbc Holdings PLC Bridge Bio Pharma, Inc. Transaction History

Hsbc Holdings PLC

$161 Billion
Q2 2025

A detailed history of Hsbc Holdings PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 6,292 shares of BBIO stock, worth $308,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,292

Previous 16,291 61.38%

Holding current value

$308,874

Previous $563,000 51.87%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$30.14 - $45.12 $301,369 - $451,154	-9,999 Reduced 61.38%	6,292 $271,000
Q1 2025 May 14, 2025	SELL	$28.12 - $37.59 $336,230 - $449,463	-11,957 Reduced 42.33%	16,291 $563,000
Q4 2024 Feb 14, 2025	BUY	$22.35 - $29.5 $103,838 - $137,057	4,646 Added 19.68%	28,248 $775,000
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $564,323 - $738,742	23,602 New	23,602 $600,000
Q1 2024 May 15, 2024	BUY	$27.35 - $40.45 $324,070 - $479,292	11,849 New	11,849 $366,000
Q4 2022 Feb 14, 2023	SELL	$6.74 - $11.52 $4,118 - $7,038	-611 Reduced 1.4%	43,184 $329,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $51,681 - $80,451	6,509 Added 17.46%	43,795 $456,000
Q2 2022 Aug 11, 2022	BUY	$5.21 - $12.14 $48,473 - $112,950	9,304 Added 33.25%	37,286 $338,000
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $205,387 - $480,171	27,982 New	27,982 $288,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $249,210 - $1.17 Million	-21,899 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $827,489 - $1.13 Million	17,655 Added 416.0%	21,899 $1.06 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $53,161 - $73,135	-1,144 Reduced 21.23%	4,244 $258,000
Q1 2021 May 14, 2021	SELL	$55.47 - $72.35 $186,878 - $243,747	-3,369 Reduced 38.47%	5,388 $331,000
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $336,093 - $622,710	8,757 New	8,757 $622,000

Others Institutions Holding BBIO

# of Institutions

392

Shares Held

187M

Call Options Held

12.7M

Put Options Held

2.28M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $7.28B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Bridge Bio Pharma, Inc. Transaction History